Rite Aid Corp (RADCQ)

[JPetroInc]

AD's retaining OPK/BioReference to perform CV19 testing nationwide will only continue to prove financially rewarding for RAD shareholders:

https://www.fool.com/investing/2020/04/21/rite-aid-chooses-opko-health-unit-for-drive-up-cor.aspx

I've looked closely at most all testing companies conducting CV19 testing in the US, and hands down OPK/BioReference is "the best of breed" regarding accuracy, 2-day turn around results and least errors in processing.

Additionally, RAD's head-on and outright aggressive 'coast to coast' undertaking of CV19 testing with U.S. Department of Health and Human Services will only continue to drive patrons to RAD stores thereby increasing the volume of sales at these stores.

https://www.hhs.gov/about/news/2020/06/30/hhs-extends-covid-19-testing-public-private-partnership.html

“This program not only provides convenient access to COVID-19 testing, it is a bridge for retailers to implement new regulatory flexibilities and expanded reimbursement options HHS has provided through private insurance, Medicare, Medicaid, and the newly expanded authority given to pharmacists to order and administer COVID-19 testing,” said Deputy Surgeon General RADM Erica Schwartz, M.D., M.P.H., who oversees the program. “Providing retailers an option for reimbursement for COVID-19 testing outside of this contract will be essential for the private sector to take over COVID-19 testing once this contract concludes. CVS has set up 1,400 additional testing sites using these regulatory flexibilities.”

The accessibility and distribution of retail and community-based pharmacies make pharmacy and retail sites the first point of contact with a healthcare professional for many Americans.

I can't wait to see 2Q20 earning on 9/28 - should be another blow away on both top & bottom numbers - and should put us over the $25 threshold - and keep us there...!